Canada

French pharma giant Sanofi recently opened a pediatric and adult vaccine manufacturing facility on its Toronto campus. The facility officially opened on May 30. According to Sanofi, the new plant significantly increases its capacity to meet growing demand in Canada and around the world for pediatric and adult vaccines for pertussis (whooping cough), diphtheria and…

Sanofi announced today that it will spend €600 million ($685 million) on a new plant in Toronto to produce its differentiated influenza vaccines. The Paris-based pharma giant’s Fluzone high-dose quadrivalent influenza vaccine has four times more antigen than a standard-dose vaccine. The vaccine’s creators specifically designed it to provide superior protection against influenza for older…

Canada is hoping to accelerate its mass-vaccination program with the authorization of Johnson & Johnson’s COVID-19 vaccine, which the FDA also recently authorized. Canada has now authorized four vaccines. Pfizer has also agreed to ramp up deliveries to the country. By the end of June, Canada could have 36.5 million vaccine doses. The country’s population is…

Roche (SWX: RO,  ROG) recently announced that it will create a Global Pharma Technical (PT) Operations site at its Canadian pharmaceutical headquarters in Mississauga, Ontario. The new operations site, announced, Oct. 16, involves a $500 investment over five years, with 200 people hired for skilled jobs by the end of this year. Roche plans to hire 300 more…

Canada reportedly signed a contract to purchase 37 million syringes from Becton Dickinson (NYSE:BDX) in preparation for a potential COVID-19 vaccine. A report in The Record revealed that Public Services & Procurement Minister Anita Anand said the country made a purchase order from the Canadian branch of BD in an effort to make sure Canada is ready for…